## Abstract Local polymeric delivery enhances IUdR radiosensitization of human malignant gliomas (MG). The combined low‐dose rate (LDR) (0.03 Gy/h) and fractionated high‐dose rate (HDR) treatments result in cures of experimental MGs. To enhance efficacy, we combined polymeric IUdR delivery, LDR, an
Human malignant glioma cell lines are sensitive to low radiation doses
✍ Scribed by Patrick D. Beauchesne; Suzanne Bertrand; Robert Branche; Steven P. Linke; Roland Revel; Jean-François Dore; Rémy M. Pedeux
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- French
- Weight
- 182 KB
- Volume
- 105
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Malignant gliomas display aggressive local behavior and are not cured by existing therapy. Some cell lines that are considered radioresistant respond to low radiation doses (<1 Gy) with increased cell killing (low‐dose hypersensitivity). In our study, 4 of 5 human glioma cell lines exhibited significant X‐ray sensitivity at doses below 1 Gy. The surviving fractions (SFs) obtained at 0.7 and/or 0.8 Gy were comparable to those at 1.5 Gy. Low‐dose hypersensitivity was evident when irradiation was combined with etoposide treatment. Repeated irradiation with low doses was markedly more effective than irradiation with single, biologically equivalent doses in decreasing SFs, inhibiting xenograft tumor growth in mice. All experiments were conducted with an accelerator used in clinics, establishing that low‐dose hypersensitivity was present following megavoltage X‐irradiation. Thus, repeated low‐dose irradiation (ultrafractionation) could greatly improve the effectiveness of radiotherapy of gliomas and could allow safe treatment of patients with cumulative doses greater than 60 Gy. © 2003 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract We investigated for the first time the ability of farnesyltransferase inhibitors (FTI) to radiosensitize human glioma. For this, human glioma cell lines were treated with the specific FTI, R115777, 48 hr prior to a 2Gy irradiation. The treatment with R115777 decreased by 45% the SF2 val
The median survival for human malignant glioma patients treated with neurosurgery and postoperative radiotherapy does not exceed one year. Only a minority of patients benefit from adjuvant chemotherapy. It was the aim of our study to determine which genomic alterations in malignant gliomas modulate
## Abstract The pure steroidal anti‐estrogens ICI 164,384 and ICI 182,780 are very potent growth inhibitors of the estrogen receptor‐positive human breast cancer cell line MCF‐7. However, long‐term treatment of MCF‐7 cells with 10^−7^ M concentrations of these compounds results in selection of prol
## Abstract Midkine (MK) is a heparin binding growth factor having functions of neurite‐outgrowth, mitogenesis and tissue repair. This molecule is involved in tumor growth and metastasis. The MK molecule consists of five exons, but there is a truncated isoform, lacking exon 3. We established SW13 c
## Abstract The original article to which this Erratum refers was published in International Journal of Cancer (Radiation Oncology Investigations) 2001; 96(2) 118–125